Variations in inflammatory markers in acute myocardial infarction: a longitudinal study

Area of Science:

• Cardiovascular Medicine
• Immunology
• Biochemistry

Background:

• Inflammation is integral to atherosclerosis, from initial plaque formation to rupture and thrombosis.
• Key inflammatory mediators include cytokines like TNF-alpha and adhesion molecules such as ICAM-1, CD40L, and P-selectin.
• Soluble forms of these molecules serve as indicators of inflammatory processes and platelet activation in cardiovascular disease.

Purpose of the Study:

• To investigate the dynamic changes in serum concentrations of specific inflammatory markers in patients following acute myocardial infarction (AMI).
• To correlate these changes with disease progression and recovery phases post-intervention.
• To assess the role of soluble CD40L, P-selectin, ICAM-1, and TNF-alpha in the context of AMI and its aftermath.

Main Methods:

• Serum samples were collected from 17 AMI patients undergoing angioplasty and 16 healthy controls.
• Measurements of soluble CD40L, P-selectin, ICAM-1, and TNF-alpha were performed using ELISA kits.
• AMI patients were assessed at diagnosis, within 24 hours, and at 2 and 40 days post-intervention, with clinical data also recorded.

Main Results:

• Soluble P-selectin levels significantly increased at infarction onset, decreased by day 2, and rose again by day 40.
• Soluble CD40L levels showed a trend of decrease until day 2, followed by an increase above control levels by day 40.
• TNF-alpha levels were consistently higher in AMI patients, becoming significant at 40 days post-recovery, while ICAM-1 showed no significant variation.

Conclusions:

• Observed variations in inflammatory markers confirm their role in AMI progression and systemic inflammation.
• Elevated sP-selectin at infarction onset indicates thrombosis and platelet activation.
• Post-recovery increases in sCD40L and TNF-alpha suggest their involvement in endothelial and myocardial tissue repair processes.